Tsuda Paige S, Du Austin L, Gabriel Rodney A, Curran Brian P
Anesthesiology, Division of Regional Anesthesia, University of California San Diego, La Jolla, USA.
Cureus. 2023 Jul 1;15(7):e41258. doi: 10.7759/cureus.41258. eCollection 2023 Jul.
Background Severe cases of carpal tunnel syndrome (CTS) are treated with surgical decompression, for which regional nerve blocks are often administered. There is little data about complications associated with these regional techniques for this surgery. The primary objective was to assess the association of ultrasound-guided regional anesthesia nerve blocks in patients undergoing carpal tunnel release with symptom resolution. Methods This single-institution, retrospective study analyzed all patients undergoing open carpal tunnel release from March 2018 to November 2020. Primary exposure was either regional anesthesia (median and ulnar nerve blocks) or non-regional anesthesia (general anesthesia or local infiltration by surgeon). The primary outcome measurement was symptom resolution at postoperative follow-up at 30-60 days. Secondary outcomes were postoperative surgical site infection, time in operating room (minutes), and post-anesthesia care unit (PACU) length of stay (min). The primary outcome was analyzed using multivariable logistic regression. Results A total of 417 patients were included in this study. Of these, 269 (64.5%) subjects received regional anesthesia as their primary anesthetic. When adjusting for confounders, the use of regional anesthesia was not associated with symptoms not improving at postoperative visit (OR 0.52, 95% CI 0.22 - 1.26, P = 0.15), postoperative surgical site infection (OR 1.47, 95% CI 0.44 - 4.85, p = 0.53), or operating room time duration (p = 0.09). However, the use of regional anesthesia was associated with an approximately 15-minute decrease in PACU length of stay (p < 0.001). Conclusions Regional anesthesia is a safe, effective, and time-efficient method for anesthesia in patients undergoing open carpal tunnel release.
严重腕管综合征(CTS)采用手术减压治疗,通常会进行区域神经阻滞。关于该手术中这些区域技术相关并发症的数据很少。主要目的是评估超声引导下区域麻醉神经阻滞与接受腕管松解术患者症状缓解之间的关联。方法:这项单机构回顾性研究分析了2018年3月至2020年11月期间所有接受开放性腕管松解术的患者。主要暴露因素为区域麻醉(正中神经和尺神经阻滞)或非区域麻醉(全身麻醉或外科医生局部浸润麻醉)。主要结局指标是术后30 - 60天随访时症状缓解情况。次要结局指标是术后手术部位感染、手术时间(分钟)和麻醉后恢复室(PACU)停留时间(分钟)。主要结局采用多变量逻辑回归分析。结果:本研究共纳入417例患者。其中,269例(64.5%)受试者接受区域麻醉作为主要麻醉方式。在调整混杂因素后,区域麻醉的使用与术后随访时症状未改善(比值比[OR]0.52,95%置信区间[CI]0.22 - 1.26,P = 0.15)、术后手术部位感染(OR 1.47,95% CI 0.44 - 4.85,P = 0.53)或手术时间(P = 0.09)无关。然而,区域麻醉的使用与PACU停留时间缩短约15分钟相关(P < 0.001)。结论:区域麻醉是开放性腕管松解术患者麻醉的一种安全、有效且省时的方法。